Myanmar

Since 2012, we’ve partnered with government, businesses, and civil society organizations to improve nutrition and newborn care, support sexual and reproductive health, strengthen immunization, and help Myanmar achieve its goal of universal health coverage by 2030.

Contact Us

No.23 D/1
Inya Myaing Road
Shwe Taung Kyar Ward 2
(Golden Valley Ward 2)
Bahan Township
Yangon, Myanmar

Phone: 95.1.511.422
Fax: 95.1.230.4781

Our Work
18 Articles
18 Articles
18 Articles
  1. Myanmar Japanese encephalitis vaccination campaign 2017
    April 24, 2019

    No longer neglected—the story (behind the story) of the Japanese encephalitis vaccine

    Dr. Nihal Abeysinghe and Dr. Kathleen Neuzil are pioneers of a nearly two-decade effort to prevent and control Japanese encephalitis (JE).

  2. PATH’s Market Dynamics team, with partners Medicines for Malaria Ventures and Global Health Strategies, visit a central warehouse in Iquitos, Peru to learn about the country’s public health procurement and supply chain system.
    April 24, 2019

    Market dynamics: Making malaria care affordable, accessible, and safe

    What happens when lifesaving products exist but are not available to the people who need them?

  3. Minzayar Oo
    April 9, 2019

    Myanmar’s push for sexual and reproductive health and rights

    PATH is part of the home-grown push in Myanmar to accelerate efforts around sexual and reproductive health and rights. Over the past few years, PATH has paved the way for policy reform and guidelines and is now looking to implement a new national policy and make it a reality.

  4. A woman gives a girl an injection as others wait behind her.
    September 20, 2018

    How a once little-used vaccine now protects millions from Japanese encephalitis

    An incurable disease sometimes referred to as “brain fever” once ravaged communities across Asia. But thanks to PATH and our partners, Japanese encephalitis is no longer the threat it once was. A 15-year effort turned a little-known vaccine from China into an internationally approved immunization tool. The vaccine has now reached an estimated 300 million children—a turning point in the battle to protect people from this dreaded disease.

  5. Healthworker and patient
    August 30, 2018

    This blood test is the key to curing the most stubborn form of malaria

    Low-cost, simple, point-of-care blood tests for G6PD enzyme deficiency are a key part of Plasmodium vivax malaria treatment, and a step towards eliminating malaria overall

  6. Young girl in Myanmar prepares to receive the Japanese encephalitis vaccine. PATH/Thet Htoo
    July 3, 2018

    How do you protect 300 million children from deadly diseases? Partnerships are key

    On the way to vaccinating 300 million children, PATH forged partnerships from local to global levels to ensure the successful and sustainable launch of Japanese encephalitis vaccine.

Load more